Metric Finance
LearnFAQ
LearnFAQ

Learn / SMTI

NASDAQ: SMTI

Sanara MedTech (SMTI) stock, explained like you're 5

Sanara MedTech trades on the Nasdaq under the ticker SMTI. It is a small cap company in the industrial specialties industry, part of the healthcare sector, with a market value of about 322 million dollars.

Ticker
SMTI
Exchange
Nasdaq
Sector
Healthcare
Industry
Industrial Specialties
Size
Small cap, about 322 million dollars

Is Sanara MedTech a small, medium or large cap company?

No. Sanara MedTech is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 322 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Sanara MedTech makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves SMTI stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • FTC requests more information on Sanara MedTech (SMTI) and MiMedx’s proposed merger. (Stock Titan)
  • MiMedx Sanara Merger Faces Fresh Regulatory Obstacle SMTI Stock Falls Below This Key Support Level For The First Time In 4 Months (Stocktwits)
  • Sanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care Growth (Yahoo Finance)
  • Sanara MedTech/MiMedx deal spread widens on FTC second request (SMTI:NASDAQ) (Seeking Alpha)
  • (SMTI) as a Liquidity Pulse for Institutional Tactics (Stock Traders Daily)

Follow SMTI in your daily brief

Each trading day at 5 PM ET we post what happened to Sanara MedTech and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow SMTI

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Sanara MedTech stock

What does Sanara MedTech do?

Sanara MedTech trades on the Nasdaq under the ticker SMTI. It is a small cap company in the industrial specialties industry, part of the healthcare sector, with a market value of about 322 million dollars.

What is the ticker symbol for Sanara MedTech?

Sanara MedTech trades under the ticker SMTI on the Nasdaq.

What is Sanara MedTech's market cap?

Sanara MedTech is a small cap stock with a market cap of about 322 million dollars.

How does Sanara MedTech make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves SMTI stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow SMTI stock every day?

Add SMTI to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow SMTI daily

A free brief on Sanara MedTech and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • STE · STERIS plc
  • ZBH · Zimmer Biomet Holdings
  • MAS · Masco Corp /De/
  • AIT · Applied Industrial Technologies

Similar stocks

  • STESTERIS plc
  • ZBHZimmer Biomet Holdings
  • MASMasco Corp /De/
  • AITApplied Industrial Technologies

Compare SMTI: SMTI vs STE, SMTI vs ZBH, SMTI vs MAS

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed